GB0111523D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0111523D0
GB0111523D0 GBGB0111523.7A GB0111523A GB0111523D0 GB 0111523 D0 GB0111523 D0 GB 0111523D0 GB 0111523 A GB0111523 A GB 0111523A GB 0111523 D0 GB0111523 D0 GB 0111523D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
solvates
compound
formula
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0111523.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0111523.7A priority Critical patent/GB0111523D0/en
Publication of GB0111523D0 publication Critical patent/GB0111523D0/en
Priority to JP2002589475A priority patent/JP2004534035A/ja
Priority to PL02367478A priority patent/PL367478A1/xx
Priority to MXPA03010285A priority patent/MXPA03010285A/es
Priority to DE60205481T priority patent/DE60205481T2/de
Priority to KR10-2003-7014660A priority patent/KR20040023600A/ko
Priority to CZ20033064A priority patent/CZ20033064A3/cs
Priority to AT02722506T priority patent/ATE301649T1/de
Priority to US10/476,194 priority patent/US7091237B2/en
Priority to IL15833202A priority patent/IL158332A0/xx
Priority to ES02722506T priority patent/ES2247322T3/es
Priority to CA002446797A priority patent/CA2446797A1/en
Priority to PCT/GB2002/002152 priority patent/WO2002092590A1/en
Priority to BR0209468-1A priority patent/BR0209468A/pt
Priority to EP02722506A priority patent/EP1392674B1/en
Priority to CNA028096940A priority patent/CN1507442A/zh
Priority to HU0304051A priority patent/HUP0304051A3/hu
Priority to ZA200308352A priority patent/ZA200308352B/en
Priority to CO03099078A priority patent/CO5540343A2/es
Priority to NO20034986A priority patent/NO20034986D0/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
GBGB0111523.7A 2001-05-11 2001-05-11 Chemical compounds Ceased GB0111523D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB0111523.7A GB0111523D0 (en) 2001-05-11 2001-05-11 Chemical compounds
HU0304051A HUP0304051A3 (en) 2001-05-11 2002-05-09 Furan and thiophene derivatives activating the human peroxisome proliferator activated receptors
US10/476,194 US7091237B2 (en) 2001-05-11 2002-05-09 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
ES02722506T ES2247322T3 (es) 2001-05-11 2002-05-09 Derivados furano y tiofeno que activan receptores actiados del proliferador de peroxisonas humano activo.
MXPA03010285A MXPA03010285A (es) 2001-05-11 2002-05-09 Derivados de furano y tiofeno que activan receptores activados por el proliferador de peroxisoma humana.
DE60205481T DE60205481T2 (de) 2001-05-11 2002-05-09 Furan and thiophen-derivate die menschliche peroxisome proliferator aktivierte rezeptoren aktivieren
KR10-2003-7014660A KR20040023600A (ko) 2001-05-11 2002-05-09 인간 퍼옥시좀 증식제 활성화되는 수용체를 활성화시키는푸란 및 티오펜 유도체
CZ20033064A CZ20033064A3 (cs) 2001-05-11 2002-05-09 Furanové a thiofenové deriváty
AT02722506T ATE301649T1 (de) 2001-05-11 2002-05-09 Furan and thiophen derivate die menschliche peroxisome proliferator aktivierte receptoren aktivieren
JP2002589475A JP2004534035A (ja) 2001-05-11 2002-05-09 ヒト・ペルオキシソーム増殖因子活性化受容体を活性化するフランおよびチオフェン誘導体
IL15833202A IL158332A0 (en) 2001-05-11 2002-05-09 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
PL02367478A PL367478A1 (en) 2001-05-11 2002-05-09 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
CA002446797A CA2446797A1 (en) 2001-05-11 2002-05-09 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
PCT/GB2002/002152 WO2002092590A1 (en) 2001-05-11 2002-05-09 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
BR0209468-1A BR0209468A (pt) 2001-05-11 2002-05-09 Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar
EP02722506A EP1392674B1 (en) 2001-05-11 2002-05-09 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
CNA028096940A CN1507442A (zh) 2001-05-11 2002-05-09 激活人的过氧化物酶体增殖物激活受体的呋喃和噻吩衍生物
ZA200308352A ZA200308352B (en) 2001-05-11 2003-10-27 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors.
CO03099078A CO5540343A2 (es) 2001-05-11 2003-11-10 Derivados de furano y tiofeno que activan receptores activados por el proliferador de la peroxisoma humana
NO20034986A NO20034986D0 (no) 2001-05-11 2003-11-10 Furan og tiofenderivater som aktiverer human peroksisom proliferator aktiverte reseptorer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0111523.7A GB0111523D0 (en) 2001-05-11 2001-05-11 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0111523D0 true GB0111523D0 (en) 2001-07-04

Family

ID=9914442

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0111523.7A Ceased GB0111523D0 (en) 2001-05-11 2001-05-11 Chemical compounds

Country Status (20)

Country Link
US (1) US7091237B2 (enExample)
EP (1) EP1392674B1 (enExample)
JP (1) JP2004534035A (enExample)
KR (1) KR20040023600A (enExample)
CN (1) CN1507442A (enExample)
AT (1) ATE301649T1 (enExample)
BR (1) BR0209468A (enExample)
CA (1) CA2446797A1 (enExample)
CO (1) CO5540343A2 (enExample)
CZ (1) CZ20033064A3 (enExample)
DE (1) DE60205481T2 (enExample)
ES (1) ES2247322T3 (enExample)
GB (1) GB0111523D0 (enExample)
HU (1) HUP0304051A3 (enExample)
IL (1) IL158332A0 (enExample)
MX (1) MXPA03010285A (enExample)
NO (1) NO20034986D0 (enExample)
PL (1) PL367478A1 (enExample)
WO (1) WO2002092590A1 (enExample)
ZA (1) ZA200308352B (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US20030171399A1 (en) 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
US7105551B2 (en) * 2000-12-20 2006-09-12 Smithkline Beecham Corporation Thiazole derivatives for treating PPAR related disorders
GB0113232D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical process
WO2003016291A1 (en) 2001-08-10 2003-02-27 Nippon Chemiphar Co., Ltd. ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
ITRM20020014A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del
US6833380B2 (en) 2002-03-07 2004-12-21 Warner-Lambert Company, Llc Compounds that modulate PPAR activity and methods of preparation
US20030207924A1 (en) * 2002-03-07 2003-11-06 Xue-Min Cheng Compounds that modulate PPAR activity and methods of preparation
US6875780B2 (en) 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation
US7553867B2 (en) 2002-09-06 2009-06-30 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
JP2005035966A (ja) * 2002-09-06 2005-02-10 Takeda Chem Ind Ltd フランまたはチオフェン誘導体およびその医薬用途
AU2003277576A1 (en) * 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
US7504433B2 (en) * 2003-01-06 2009-03-17 Eli Lilly And Company Thiophene derivative PPAR modulators
US7244763B2 (en) 2003-04-17 2007-07-17 Warner Lambert Company Llc Compounds that modulate PPAR activity and methods of preparation
EP1493739A1 (fr) * 2003-07-03 2005-01-05 Warner-Lambert Company LLC Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US7223761B2 (en) 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
RU2374230C2 (ru) 2003-11-05 2009-11-27 Ф.Хоффманн-Ля Рош Аг Фенильные производные в качестве ppar агонистов
US7456218B2 (en) 2003-12-25 2008-11-25 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl) propanoic acid derivatives
WO2005063725A1 (ja) 2003-12-26 2005-07-14 Takeda Pharmaceutical Company Limited フェニルプロパン酸誘導体
GB0403148D0 (en) * 2004-02-12 2004-03-17 Smithkline Beecham Corp Chemical compounds
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
MX2007010511A (es) * 2005-02-28 2007-11-07 Nippon Chemiphar Co Activador para el receptor ( activador del proliferador peroxisoma.
US7982050B2 (en) 2005-05-07 2011-07-19 Seoul National University Industry Foundation Process for preparing ligands of PPARdelta and the intermediate compounds for preparing the same
RU2007148439A (ru) * 2005-05-25 2009-06-27 Ниппон Кемифар Ко., Лтд. (JP) Активатор для рецептора, активируемого пролифератором пероксисом
BRPI0616465A2 (pt) 2005-09-29 2011-06-21 Sanofi Aventis derivados de fenil-[1,2,4]-oxadiazol-5-ona com grupo fenila, bem como seu uso, composição farmacêutica compreendo os mesmos e processo de preparação da referida composição farmacêutica
NZ566877A (en) 2005-09-29 2010-05-28 Sanofi Aventis Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
US20090012133A1 (en) * 2006-01-10 2009-01-08 Smithkline Beecham Corporation Polymorphic Form of -Acetic Acid
EP2014652B1 (en) 2006-04-18 2014-08-06 Nippon Chemiphar Co., Ltd. Activating agent for peroxisome proliferator activated receptor
JO2868B1 (en) * 2006-08-22 2015-03-15 رانبكسي لابوراتوريز ليمتد Inhibitors of metabolic protein protein enzyme
FR2910894A1 (fr) * 2006-12-29 2008-07-04 Genfit Sa Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation.
EP2114396A4 (en) 2006-12-29 2010-03-10 Salk Inst For Biological Studi METHOD FOR IMPROVING TRAINING PERFORMANCE
JP2010519308A (ja) * 2007-02-23 2010-06-03 イーライ リリー アンド カンパニー ペルオキシソーム増殖剤活性化受容体修飾因子
US20100063041A1 (en) * 2007-03-07 2010-03-11 Ho-Sang Moon Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same
DE102008007400A1 (de) * 2008-02-04 2009-08-06 Bayer Healthcare Ag Substituierte Furane und ihre Verwendung
MX2010011252A (es) 2008-04-15 2010-11-30 Nippon Chemiphar Co Activador para el receptor activado por el proliferador de peroxisoma.
CN101643451B (zh) * 2008-08-07 2013-03-06 浙江海正药业股份有限公司 过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法
CN103298469A (zh) 2010-08-31 2013-09-11 首尔大学校产学协力财团 PPARδ激动剂的胎儿重编程的用途
WO2014159054A1 (en) * 2013-03-14 2014-10-02 Janssen Pharmaceutica Nv Gpr120 agonists for the treatment of type ii diabetes
NZ710855A (en) * 2013-03-14 2020-03-27 Dow Agrosciences Llc Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
US11634387B2 (en) 2019-09-26 2023-04-25 Abionyx Pharma Sa Compounds useful for treating liver diseases
WO2022189856A1 (en) * 2021-03-08 2022-09-15 Abionyx Pharma Sa Compounds useful for treating liver diseases
CA3212825A1 (en) * 2021-03-08 2022-09-15 Abionyx Pharma Sa Compounds useful for treating liver diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9817118D0 (en) * 1998-08-07 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
HRP20010795A2 (en) 1999-04-28 2003-02-28 Aventis Pharma Gmbh Di-aryl acid derivatives as ppar receptor ligands

Also Published As

Publication number Publication date
US20040157890A1 (en) 2004-08-12
KR20040023600A (ko) 2004-03-18
JP2004534035A (ja) 2004-11-11
DE60205481T2 (de) 2006-05-24
BR0209468A (pt) 2004-08-03
HUP0304051A2 (hu) 2004-04-28
ES2247322T3 (es) 2006-03-01
ATE301649T1 (de) 2005-08-15
CA2446797A1 (en) 2002-11-21
CO5540343A2 (es) 2005-07-29
IL158332A0 (en) 2004-05-12
PL367478A1 (en) 2005-02-21
WO2002092590A1 (en) 2002-11-21
ZA200308352B (en) 2005-01-27
EP1392674B1 (en) 2005-08-10
CZ20033064A3 (cs) 2004-02-18
NO20034986L (no) 2003-11-10
NO20034986D0 (no) 2003-11-10
US7091237B2 (en) 2006-08-15
EP1392674A1 (en) 2004-03-03
CN1507442A (zh) 2004-06-23
MXPA03010285A (es) 2004-03-09
DE60205481D1 (de) 2005-09-15
HUP0304051A3 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
DE60112974D1 (en) Carbolinderivate
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MY120090A (en) Chemical compounds.
GB0225475D0 (en) Therapeutic agents
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
DE60216233D1 (en) Carbolinderivate
GB0124933D0 (en) Chemical compounds
IL165262A (en) Kinase inhibitors and pharmaceutical compositions containing them
MXPA02012076A (es) Compuestos quimicos.
GB0318438D0 (en) Early entry
MXPA03002911A (es) Compuestos quimicos.
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
MXPA03010285A (es) Derivados de furano y tiofeno que activan receptores activados por el proliferador de peroxisoma humana.
MXPA02012659A (es) Derivados de pirazindiona condensados.
MXPA03009750A (es) Compuestos quimicos.
IL145633A0 (en) Pharmaceutical compounds
MXPA03010761A (es) Combinaciones farmaceuticas.
DE60205899D1 (en) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
PT1578741E (pt) Compostos aromáticos como agentes antiinflamatórios, imunoreguladores e antiproliferativos
MXPA04006041A (es) Antivirales de piridoquinoxalina.
TW200508199A (en) Novel compound
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
AU2003223340A8 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)